April 27, 2022 01:08 PM Eastern Daylight Time

BUSINESS WIRE

Riassunto: iXensor riceve un investimento strategico da Rohto Pharmaceutical con un accordo di licenza tecnologica separato

iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

Opens in new window

Download

Full Size JPEG, 2220x955, 261.3 KB
Small JPEG, 480x206, 63.9 KB
Preview JPEG, 144x62, 31.4 KB
Thumbnail JPEG, 72x31, 27.0 KB

Smart Multimedia Gallery

iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

http://www.businesswire.it/multimedia/it/20220426005102/it/5198214/

View and Share Logo

Share

Email

All News | News with Multimedia > Press Release: Riassunto: iXensor riceve un investimento strat...